CY1114492T1 - Συνδυασμος αλφα 7 νικοτινικων αγωνιστων και αντιψυχωσικων - Google Patents

Συνδυασμος αλφα 7 νικοτινικων αγωνιστων και αντιψυχωσικων

Info

Publication number
CY1114492T1
CY1114492T1 CY20131100896T CY131100896T CY1114492T1 CY 1114492 T1 CY1114492 T1 CY 1114492T1 CY 20131100896 T CY20131100896 T CY 20131100896T CY 131100896 T CY131100896 T CY 131100896T CY 1114492 T1 CY1114492 T1 CY 1114492T1
Authority
CY
Cyprus
Prior art keywords
antipsychotic
fighters
nicotine
alpha combination
alpha
Prior art date
Application number
CY20131100896T
Other languages
English (en)
Inventor
Merouane Bencherif
Gregory J Gatto
Terry Hauser
Kristen G Jordan
Sharon R Letchworth
Original Assignee
Targacept, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Targacept, Inc. filed Critical Targacept, Inc.
Publication of CY1114492T1 publication Critical patent/CY1114492T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Η παρούσα εφεύρεση αναφέρεται σε ένα συνεργικό συνδυασμό ενός άλφα 7 (α7) νικοτινικού αγωνιστή και ενός αντιψυχωσικού παράγοντα.
CY20131100896T 2008-02-13 2013-10-10 Συνδυασμος αλφα 7 νικοτινικων αγωνιστων και αντιψυχωσικων CY1114492T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2828208P 2008-02-13 2008-02-13
EP09709577.2A EP2254598B1 (en) 2008-02-13 2009-02-13 Combination of alpha 7 nicotinic agonists and antipsychotics

Publications (1)

Publication Number Publication Date
CY1114492T1 true CY1114492T1 (el) 2016-10-05

Family

ID=40902222

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20131100896T CY1114492T1 (el) 2008-02-13 2013-10-10 Συνδυασμος αλφα 7 νικοτινικων αγωνιστων και αντιψυχωσικων

Country Status (26)

Country Link
US (1) US20110059947A1 (el)
EP (2) EP2633868A1 (el)
JP (1) JP2011511845A (el)
KR (1) KR20100113163A (el)
CN (2) CN101977628A (el)
AU (1) AU2009214625A1 (el)
BR (1) BRPI0907570A2 (el)
CA (1) CA2715268A1 (el)
CO (1) CO6290706A2 (el)
CY (1) CY1114492T1 (el)
DK (1) DK2254598T3 (el)
EC (1) ECSP10010471A (el)
ES (1) ES2430622T3 (el)
HK (1) HK1147954A1 (el)
HR (1) HRP20130749T1 (el)
IL (1) IL207389A0 (el)
MX (1) MX2010008875A (el)
NZ (1) NZ587312A (el)
PL (1) PL2254598T3 (el)
PT (1) PT2254598E (el)
RS (1) RS52941B (el)
RU (1) RU2481123C2 (el)
SG (1) SG188144A1 (el)
SI (1) SI2254598T1 (el)
WO (1) WO2009102962A2 (el)
ZA (1) ZA201005999B (el)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8314119B2 (en) * 2006-11-06 2012-11-20 Abbvie Inc. Azaadamantane derivatives and methods of use
SA08290475B1 (ar) * 2007-08-02 2013-06-22 Targacept Inc (2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه
BR112013005434A2 (pt) 2010-09-23 2016-06-07 Abbott Lab novo mono-hidrato de derivados de aza-adamantano
CA2824900A1 (en) * 2011-01-18 2012-07-26 Targacept, Inc. Treatment of cognitive dysfunction in schizophrenia
US9139576B2 (en) 2011-05-03 2015-09-22 Merck Sharp & Dohme Corp. Aminomethyl biaryl benzotriazole derivatives
EP2905279A4 (en) * 2012-10-02 2016-04-20 Sumitomo Dainippon Pharma Co Ltd imidazole
CN110087640A (zh) 2016-12-20 2019-08-02 罗曼治疗系统股份公司 包含阿塞那平的透皮治疗系统
KR102614709B1 (ko) 2016-12-20 2023-12-18 에르테에스 로만 테라피-시스테메 아게 아세나핀 및 폴리실록산 또는 폴리이소부틸렌을 함유하는 경피흡수 치료 시스템
CN108727416B (zh) * 2017-04-20 2021-03-09 北京大学 三环杂芳香体系酰胺衍生物及其制备和用途
US11033512B2 (en) 2017-06-26 2021-06-15 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine and silicone acrylic hybrid polymer
CN107469087A (zh) * 2017-09-10 2017-12-15 孙永丽 用于治疗精神病的制剂
KR20210022656A (ko) 2018-06-20 2021-03-03 에르테에스 로만 테라피-시스테메 아게 아세나핀을 함유하는 경피 치료 시스템
EP4274660A1 (en) * 2021-01-08 2023-11-15 IFM Due, Inc. Compounds and compositions for treating conditions associated with sting activity
DE102022114269A1 (de) 2022-06-07 2023-12-07 Rational Aktiengesellschaft Gargerät mit einem Selbstreinigungssystem sowie ein Verfahren zum Ändern von Reinigungsparametern für das Gargerät

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5597919A (en) 1995-01-06 1997-01-28 Dull; Gary M. Pyrimidinyl or Pyridinyl alkenyl amine compounds
US5712270A (en) 1995-11-06 1998-01-27 American Home Products Corporation 2-arylamidothiazole derivatives with CNS activity
US5616716A (en) 1996-01-06 1997-04-01 Dull; Gary M. (3-(5-ethoxypyridin)yl)-alkenyl 1 amine compounds
SE9600683D0 (sv) 1996-02-23 1996-02-23 Astra Ab Azabicyclic esters of carbamic acids useful in therapy
US5663356A (en) 1996-04-23 1997-09-02 Ruecroft; Graham Method for preparation of aryl substituted alefinic secondary amino compounds
AR013184A1 (es) 1997-07-18 2000-12-13 Astrazeneca Ab Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis
DE69913520T2 (de) 1998-06-01 2004-11-25 Ortho-Mcneil Pharmaceutical, Inc. Tetrahydronaphtalene verbindungen und deren verwendung zur behandlung von neurodegenerativen krankheiten
US6953855B2 (en) * 1998-12-11 2005-10-11 Targacept, Inc. 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
SE9904176D0 (sv) 1999-11-18 1999-11-18 Astra Ab New use
EP1235570A2 (en) * 1999-12-10 2002-09-04 Wyeth Combinations of (s)-2-(benzylamino-methyl)-2,3,8,9,-tetrahydro-7h-1,4-dioxino(2,3)-e indol-8-one and neuroleptics
DE20122417U1 (de) * 2000-06-27 2005-08-04 Laboratorios S.A.L.V.A.T., S.A., Esplugues De Llobregat Von Arylalkylaminen abgeleitete Carbamate
AU2001282873A1 (en) 2000-08-18 2002-03-04 Pharmacia And Upjohn Company Quinuclidine-substituted aryl compounds for treatment of disease
JP2004506735A (ja) 2000-08-18 2004-03-04 ファルマシア・アンド・アップジョン・カンパニー 疾患治療用キヌクリジン置換アリール化合物
US6492386B2 (en) 2000-08-18 2002-12-10 Pharmacia & Upjohn Company Quinuclidine-substituted aryl compounds for treatment of disease
WO2002015662A2 (en) 2000-08-21 2002-02-28 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists
EP1311505A2 (en) 2000-08-21 2003-05-21 PHARMACIA & UPJOHN COMPANY Quinuclidine-substituted heteroaryl moieties for treatment of disease ( nicotinic acetylcholine receptor ligands )
US6500840B2 (en) 2000-08-21 2002-12-31 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease
US6554086B1 (en) * 2000-10-27 2003-04-29 Invacare Corporation Obstacle traversing wheelchair
JP4445704B2 (ja) 2000-12-22 2010-04-07 アルミラル・ソシエダッド・アノニマ キヌクリジンカルバメート誘導体およびｍ３アンダゴニストとしてのそれらの使用
AU2003217275A1 (en) * 2002-02-19 2003-09-09 Pharmacia And Upjohn Company Azabicyclic compounds for the treatment of disease
CA2506529A1 (en) * 2002-12-06 2004-06-24 Pharmacia & Upjohn Company Llc Crystalline fumarate salts of 1-azabicyclo[2.2.2]oct substituted furo[2,3-c]pyridinyl carboxamide and compositions and preparations thereof
TW200502222A (en) * 2003-04-02 2005-01-16 Novartis Ag Use of 10-hydroxy-10,11-dihydrocarbamazepine derivatives for the treatment of affective disorders
WO2004099202A1 (en) * 2003-05-05 2004-11-18 Pharmacia & Upjohn Company Llc Quinuclidines substituted bentodioxine carboxamides for the treatment of neurodegenerative diseases
US7309699B2 (en) * 2003-12-22 2007-12-18 Abbott Laboratories 3-Quinuclidinyl amino-substituted biaryl derivatives
CA2549638A1 (en) * 2003-12-23 2005-07-14 Pfizer Products Inc. Therapeutic combination for cognition enhancement and psychotic disorders
EP1863485A2 (en) * 2005-03-18 2007-12-12 Abbott Laboratories Alpha7 neuronal nicotinic receptor ligand and antipsychotic compositions

Also Published As

Publication number Publication date
CA2715268A1 (en) 2009-08-20
ZA201005999B (en) 2011-05-25
RS52941B (en) 2014-02-28
MX2010008875A (es) 2010-08-31
CO6290706A2 (es) 2011-06-20
EP2254598A2 (en) 2010-12-01
CN103143023A (zh) 2013-06-12
HRP20130749T1 (en) 2013-10-11
RU2481123C2 (ru) 2013-05-10
EP2254598B1 (en) 2013-07-10
IL207389A0 (en) 2010-12-30
PT2254598E (pt) 2013-10-16
WO2009102962A3 (en) 2009-10-08
DK2254598T3 (da) 2013-07-29
ES2430622T3 (es) 2013-11-21
BRPI0907570A2 (pt) 2019-09-24
PL2254598T3 (pl) 2013-12-31
WO2009102962A2 (en) 2009-08-20
EP2633868A1 (en) 2013-09-04
KR20100113163A (ko) 2010-10-20
SI2254598T1 (sl) 2013-10-30
US20110059947A1 (en) 2011-03-10
AU2009214625A1 (en) 2009-08-20
ECSP10010471A (es) 2010-10-30
SG188144A1 (en) 2013-03-28
JP2011511845A (ja) 2011-04-14
HK1147954A1 (en) 2011-08-26
RU2010137787A (ru) 2012-03-20
NZ587312A (en) 2011-12-22
CN101977628A (zh) 2011-02-16

Similar Documents

Publication Publication Date Title
CY1114492T1 (el) Συνδυασμος αλφα 7 νικοτινικων αγωνιστων και αντιψυχωσικων
CY1120961T1 (el) Δοσολογικες μορφες απο του στοματος που περιλαμβανουν αντιαιμοπεταλιακο παραγοντα και αναστολεα οξεος
CY1118007T1 (el) Μεθοδοι για την χορηγηση υπογλυκαιμικων μεσων
CY1119643T1 (el) Συνδυασμοι που περιεχουν μεθοτρεξατη και αναστολεις της dhodh
CY1121135T1 (el) Ενωσεις υποκατεστημενης τετρακυκλιnhς για την θεραπευτικη αγωγη φλεγμονωδων διαταραχων του δερματος
EA201170884A1 (ru) Производные пиперидина, пригодные в качестве антагонистов орексина
ATE496051T1 (de) Pyrazolotetrahydropyridinderivate als orexinrezeptorantagonisten
AU2009303758A8 (en) Benzoquinoline inhibitors of vesicular monoamine transporter 2
EA200900091A1 (ru) Новые показания к применению прямых ингибиторов тромбина в лечении сердечно-сосудистых заболеваний
DK1776011T3 (da) Fungicid sammensætning, indeholdende et syreamidderivat
BR112014012524A2 (pt) composições compreendendo um componente de estabilidade do prazo de validade
SV2010003631A (es) Aril pirrolinas insecticidas
ME01532B (me) Jedinjenja
ECSP099628A (es) Derivados de quinolina como fungicidas
DE112007000745A5 (de) Die Tornadormaschine - Ein Nebel-Wirbler, der als Effektgerät, Luftbefeuchter und Aerosolgenerator einsetzbar ist
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
CY1113102T1 (el) Ενωσεις φαινυλπροπιοναμιδιου και η χρηση αυτων
CL2011003147A1 (es) Compuestos derivados de n-(1-4-(1h-pirazol-5-il)ftalazina-1-il) piperidina-4-il) benzamida; composicion farmaceutica que los contiene, utiles como antagonista de la trayectoria de hedgehog, en el tratamiento del cancer.
CY1113435T1 (el) Φαρμακευτικη συνθεση που περιλαμβανει παραγωγο πυραζινης, και μεθοδος χρησης παραγωγου πυραζινης σε συνδυασμο
CY1112724T1 (el) Παραγωγα ανθρακικης κουινουκλιδινης και ιατρικη συνθεση αυτων
BRPI0814772A2 (pt) Indazóis substituídos por 5-piridinona
CY1115437T1 (el) Υδροξυμεθυλοκυκλοεξυλαμινες
ATE458740T1 (de) 1,4,5,6,7,8-hexahydro-1,2,5-triaza-azulen- derivate als orexinrezeptor-antagonisten
MX2010006206A (es) Derivados de oxindol substituidos por 5-halogeno y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina.
MX2009013982A (es) Composiciones que comprenden inhibidores de triptofano hidroxilasa.